Google Chrome
Safari
Firefox
Edge
Press Release / Mar 19, 2018
Hovione reports on recent capacity expansion and future plans to support growth
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Search
Dispersome®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Release / May 04, 2020
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Effective May 1st, 2020
Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner Interview
Outsourced Pharma, April 2023
Press Release / Sep 26, 2025
Hovione honored with the Leonardo da Vinci Prize 2025
Presented by the Hénokiens Association and the Château du Clos Lucé